167 related articles for article (PubMed ID: 22535617)
1. Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma.
Quadros CA; Falcão MF; Carvalho ME; Ladeia PA; Lopes A
J Surg Oncol; 2012 Nov; 106(6):653-8. PubMed ID: 22535617
[TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging: preliminary results.
Quadros CA; Lopes A; Araújo I; Fahel F; Bacellar MS; Dias CS
Ann Surg Oncol; 2006 Dec; 13(12):1617-21. PubMed ID: 17009148
[TBL] [Abstract][Full Text] [Related]
3. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy for rectal adenocarcinoma staging.
Quadros CA; Lopes A; Araújo I
Jpn J Clin Oncol; 2010 Aug; 40(8):746-53. PubMed ID: 20457722
[TBL] [Abstract][Full Text] [Related]
4. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
5. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
6. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.
Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T
Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895
[TBL] [Abstract][Full Text] [Related]
8. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
[TBL] [Abstract][Full Text] [Related]
10. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
11. Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg; 2009 Jun; 249(6):960-4. PubMed ID: 19474698
[TBL] [Abstract][Full Text] [Related]
12. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
13. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
Kneist W; Heintz A; Wolf HK; Junginger T
Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
[TBL] [Abstract][Full Text] [Related]
14. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer.
Wang C; Zhou ZG; Yu YY; Li Y; Lei WZ; Cheng Z; Chen ZX
Eur J Surg Oncol; 2007 May; 33(4):463-7. PubMed ID: 17081722
[TBL] [Abstract][Full Text] [Related]
15. The role of para-aortic lymphadenectomy in surgical management of patients with stage N+ rectal cancer below the peritoneal reflection.
Liu YL; Wang YH; Yang YM; Li MQ; Jiang SX; Wang XS
Cell Biochem Biophys; 2012 Jan; 62(1):41-6. PubMed ID: 21833674
[TBL] [Abstract][Full Text] [Related]
16. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
17. Lateral pelvic lymphadenectomy and total nerve sparing for locally advanced rectal cancer in Western patients.
Di Matteo G; Peparini N; Maturo A; Di Matteo FM; Zeri KP; Redler A; Mascagni D
Panminerva Med; 2001 Jun; 43(2):95-101. PubMed ID: 11449179
[TBL] [Abstract][Full Text] [Related]
18. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma.
Ballian N; Yamane B; Leverson G; Harms B; Heise CP; Foley EF; Kennedy GD
Ann Surg Oncol; 2010 Jun; 17(6):1606-13. PubMed ID: 20077020
[TBL] [Abstract][Full Text] [Related]
19. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
[TBL] [Abstract][Full Text] [Related]
20. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer.
Huh JW; Kim YJ; Kim HR
Ann Surg; 2012 Jan; 255(1):70-8. PubMed ID: 22133895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
